Previous Close | 85.28 |
Open | 86.46 |
Bid | 88.59 x 400 |
Ask | 88.68 x 400 |
Day's Range | 85.10 - 89.28 |
52 Week Range | 36.90 - 98.82 |
Volume | |
Avg. Volume | 1,423,095 |
Market Cap | 10.7B |
Beta (5Y Monthly) | 1.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 6,816 shares of the company on April 15, 2024, according to a recent SEC Filing.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Natera fair value estimate is US$119 Natera's US$96.71 share...
In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artificial intelligence. According to The Journal of mHealth, the focus […]